Organizations
Conferences
Info & Opinion
October 7, 2008
A few news bulletins on Aris Global, Oracle, Alphadas, Duke University and Quanticate.
With bulletins about Octagon Research, TrialStat, Innovaderm, Phase Forward, AG Mednet, Chiltern, EPS, Frontage Laboratories, Advanced Biomedical Research, Microsoft and TranSenda.
ClinPhone’s David Stein discusses the challenges of achieving wide, global deployment of EDC.
Helping clinical trial professionals get the most out of EDC systems, Paula McHale says, requires paying more attention to training.
How to take the technology to the next level? ClinPhone’s David Stein weighs in. The first of a five-part series.
Is electronic data capture (EDC) a commodity? Is it a matter of “anybody can do it, let’s just find the cheapest supplier”? Or is EDC more akin to spine surgery, with different levels of expertise producing divergent outcomes? That debate has been simmering in the industry for a decade, and… more...
A Japanese pharma, Astellas, chose Medidata Solutions for all of its electronic data capture (EDC) needs in trials in Asia, North America and Europe. Astellas is the successor firm to two earlier Japanese concerns, Fujisawa Pharmaceutical and Yamanouchi Pharmaceutical. The contract may not be a large one for an EDC… more...
Deloitte named the next batch of Fast 500 companies. etrials is 363rd on the list. Since 2001, etrials says, it has grown its revenues by 345 percent; this is the company’s second consecutive appearance on the list. “Sophisticated technology is becoming the norm and is in almost everything in the… more...
DSG has launched a registry for the American Society for Cataract and Refractive Surgery (ASCRS). The project is being led by R. Doyle Stulting, M.D., Ph.D., an eye doctor at Emory University who is chair of the ASCRS Refractive Clinical Committee. Ectasia is not a mood disorder but a complication… more...
Phase Forward has unveiled a new version of software that helps identify drug safety issues and manage the data in a non-proprietary, Clinical Data Interchange Standards Consortium (CDISC-compliant) manner. The latest version of the Clinical Trials Signal Detection system (CTSD) includes “a newly developed issue cluster mining technique, enhanced statistical… more...
Nextrials announced it had been selected in midstream by ArQule to take over data-capture chores in a Phase I-II study. Arqule recently exited the chemistry business to focus its quest to develop new drugs using its own scientific tools. ArQule says it has ongoing projects with Roche; former collaborations include… more...
Clinical data management is not really an endangered species. But it is threatened. That’s because some companies believe that massive, traditional systems to manage clinical trial data could be made obsolete by electronic data capture (EDC) tools that do some of the same tasks. An Asian contract research organization (CRO)… more...
Oracle is buying Sunopsis, a firm that specializes in data integration. The company is based in Burlington, Mass., near Oracle’s pharmacuetical division. Sunopsis customers in pharma include Aventis, Lilly, Pfizer and Roche. In its latest acquisition, for which no price was disclosed, the database giant did say that the new… more...
The New York Times has a nice piece on the political mess around the nomination of FDA head Andrew von Eschenbach, who’s been doing the job for a year. During the 6 years of the Bush administration, the NYT points out, the FDA has had a confirmed leader for 18… more...
OmniComm Systems, out of Florida, signed up a customer in Mountain View, California. Broncus Technologies will use OmniComm’s systems for both electronic data capture (EDC) and clinical trial management (CTM). “With TrialMaster, we have the ability to practically eliminate the data visibility gap that occurs with paper-based trials. Utilizing the… more...